ARCT - Arcturus Therapeutics Holdings Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.50
DETAILS
HIGH:
$25.00
LOW:
$20.00
MEDIAN:
$22.50
CONSENSUS:
$22.50
UPSIDE:
220.06%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 67.2 | 138.4 | 157.7 | 205.8 | 12.4 | 9.5 | 20.8 | 15.8 | 13.0 | 20.4 | 6.1 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 3.0 | 0 | 0 | 0 | 0 | 55.9 | 0 | 17.0 | 0.4 | 0.3 | 0.1 | 0 | 0 | 0 | 0 |
| Gross Profit | 64.2 | 138.4 | 157.7 | 205.8 | 12.4 | (46.4) | 20.8 | (1.2) | 12.6 | 20.1 | 6.1 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 112.2 | 195.2 | 192.1 | 147.8 | 173.8 | 57.8 | 33.6 | 17.0 | 15.9 | 18.4 | 13.5 | 25.1 | 7.1 | 0.8 | 1.8 |
| SG&A Expenses | 46.1 | 52.8 | 52.9 | 46.1 | 41.5 | 25.1 | 12.7 | 20.6 | 7.6 | 5.4 | 5.0 | 5.8 | 3.2 | 0.7 | 2.1 |
| Other Expenses | (19.1) | (13.9) | (9.1) | (0.2) | 0 | (57.8) | 0 | 0 | (0.3) | 1.4 | 1.2 | 2.1 | 0 | 0 | 0 |
| Operating Expenses | 139.2 | 234.1 | 236.0 | 193.6 | 215.2 | 25.1 | 46.3 | 37.6 | 23.5 | 25.2 | 19.7 | 33.1 | 10.3 | 1.5 | 3.9 |
| Operating Income | |||||||||||||||
| Operating Income | (75.0) | (95.7) | (78.2) | 12.2 | (202.9) | (71.5) | (25.5) | (21.8) | (10.5) | (25.2) | (19.7) | (33.1) | (10.3) | (1.5) | (3.9) |
| Interest Expense | 0 | 0 | 0.8 | 3.0 | 2.7 | 0.8 | 0.9 | 0.2 | 0.1 | 0.3 | 0.3 | 0.0 | 0.2 | 0.1 | 0.0 |
| Interest Income | 10.1 | 15.2 | 17.4 | 2.6 | 0.8 | 0.5 | 0.4 | 0.5 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 |
| Profitability | |||||||||||||||
| EBITDA | (71.9) | (77.4) | (24.2) | 13.7 | (201.7) | (70.6) | (24.5) | (20.7) | (10.3) | (0.9) | (1.7) | (32.8) | (10.3) | (1.5) | (3.9) |
| EBIT | (75.0) | (80.9) | (27.1) | 12.2 | (202.9) | (71.5) | (25.1) | (21.3) | (10.8) | (1.2) | (1.6) | (32.8) | (10.3) | (1.5) | (3.9) |
| Income Before Tax | (65.8) | (80.9) | (27.9) | 10.6 | (203.7) | (72.1) | (26.0) | (21.8) | (10.9) | (24.5) | (19.4) | (32.9) | (10.5) | (1.6) | (3.9) |
| Income Tax Expense | 0 | (0.0) | 1.8 | 1.3 | 0 | 0 | 0 | 0.2 | 0.0 | 0.1 | 0.1 | (0.0) | 0.1 | 0 | 0.0 |
| Net Income | (65.8) | (80.9) | (29.7) | 9.3 | (203.7) | (72.1) | (26.0) | (21.8) | (10.9) | (24.6) | (19.4) | (32.8) | (10.5) | (1.6) | (3.9) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | -3.55 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
| EPS (Diluted) | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | -3.55 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
| Shares Outstanding | 27.4 | 27 | 26.6 | 26.4 | 26.3 | 20.3 | 12.1 | 10.1 | 3.1 | 3.9 | 3.1 | 2.0 | 1.5 | 1.6 | 1.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 230.9 | 237.0 | 292.0 | 391.9 | 370.5 | 462.9 | 71.4 | 36.7 | 25.0 | 2.3 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.6 | 47.9 |
| Net Receivables | 5.6 | 4.0 | 32.1 | 2.8 | 3.4 | 2.1 | 2.2 | 4.5 | 0.5 | 3.6 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.5 | (0.5) |
| Other Current Assets | 5.0 | 65.0 | 55 | 8.7 | 0 | 0 | 0 | 0 | 0.8 | 0.1 |
| Total Current Assets | 241.4 | 306.0 | 386.6 | 403.3 | 379.0 | 467.8 | 74.3 | 41.8 | 50.9 | 51.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 27.8 | 36.2 | 40.9 | 45.0 | 11.3 | 8.6 | 7.5 | 2.0 | 1.0 | 0.2 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.9 | 0 | 1.9 | 0 | 0.5 | 0 | 0.3 | 0.3 | 0.1 | 0 |
| Other Non-Current Assets | 0 | 1.9 | 0 | 2.1 | 2.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Total Non-Current Assets | 29.7 | 38.1 | 42.8 | 47.1 | 13.9 | 8.7 | 7.9 | 2.4 | 1.2 | 0.3 |
| Total Assets | 271.1 | 344.1 | 429.4 | 450.4 | 392.8 | 476.5 | 82.1 | 44.2 | 52.0 | 51.6 |
| Current Liabilities | ||||||||||
| Account Payables | 4.2 | 7.2 | 5.3 | 7.4 | 10.1 | 10.8 | 5.8 | 2.4 | 1.8 | 3.4 |
| Short-Term Debt | 4.2 | 0 | 0 | 60.7 | 22.5 | 1.2 | 0 | 0 | 0 | 0.1 |
| Deferred Revenue | 8.2 | 21.9 | 47.3 | 36.1 | 0 | 0 | 0 | 6.3 | 6.5 | 4.2 |
| Other Current Liabilities | 19.7 | 13.3 | 18.5 | 4.0 | 46.3 | 24.7 | 10.3 | 8.5 | 1.0 | 0.4 |
| Total Current Liabilities | 36.4 | 65.5 | 82.0 | 127.0 | 99.5 | 49.5 | 21.3 | 12.6 | 11.0 | 4.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 40.6 | 13.8 | 15.0 | 9.9 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.6 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0.5 | 2.8 | 19.9 | 12.5 | 15.2 | 8.1 | 0 | 0.0 |
| Total Non-Current Liabilities | 20.8 | 37.6 | 68.9 | 53.1 | 65.1 | 30.4 | 35.0 | 18.0 | 7.2 | 3.4 |
| Total Liabilities | 57.2 | 103.1 | 150.9 | 180.1 | 164.6 | 79.9 | 56.4 | 30.6 | 18.2 | 4.3 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 |
| Retained Earnings | (514.6) | (448.8) | (367.9) | (338.1) | (347.5) | (143.8) | (71.7) | (44.9) | (23.1) | (95.6) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) |
| Total Stockholders' Equity | 214.0 | 241.0 | 278.5 | 270.3 | 228.2 | 396.6 | 25.8 | 13.6 | 33.8 | 47.2 |
| Total Liabilities & Equity | 271.1 | 344.1 | 429.4 | 450.4 | 392.8 | 476.5 | 82.1 | 44.2 | 52.0 | 51.6 |
| Debt Metrics | ||||||||||
| Total Debt | 25.0 | 28.6 | 30.2 | 94.8 | 69.1 | 20.8 | 20.7 | 9.9 | 0 | 0.1 |
| Net Debt | (205.9) | (208.5) | (261.8) | (297.1) | (301.3) | (442.1) | (50.7) | (26.8) | (25.0) | (2.2) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (65.8) | (80.9) | (29.7) | 9.3 | (203.7) | (72.1) | (26.0) | (21.8) | (10.9) | (24.6) |
| Depreciation & Amortization | 3.0 | 3.5 | 3.0 | 1.5 | 1.2 | 0.9 | 0.7 | 0.6 | 0.4 | 0.1 |
| Stock-Based Compensation | 25.4 | 38.0 | 34.6 | 30.6 | 28.9 | 6.8 | 2.0 | 1.3 | 2.2 | 2.5 |
| Change in Working Capital | (39.2) | (20.8) | 7.4 | (12.6) | 32.6 | 21.2 | 16.0 | (1.2) | 7.4 | 2.7 |
| Other Non-Cash Items | 2.3 | 0.5 | (33.4) | 3.1 | 5.9 | 0.4 | 0.9 | 0.0 | 0.5 | 0.1 |
| Operating Cash Flow | (74.3) | (59.7) | (18.1) | 32.0 | (135.0) | (42.9) | (6.4) | (20.8) | (0.5) | (19.2) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.2) | (0.6) | (2.9) | (7.7) | (3.4) | (1.7) | (0.8) | (1.5) | (0.3) | (0.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | (20.0) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (6.6) | 0 | (17.4) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.2 | 10.6 | 22.3 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.6 | 0.0 | 20.0 |
| Investing Cash Flow | (0.2) | (0.6) | (2.9) | (7.7) | (3.4) | (1.7) | (0.8) | 22.1 | 10.4 | 4.9 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | (27.4) | (5) | 46.6 | 0 | 4.9 | 9.9 | 5.7 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 4.7 | 2.7 | 1.7 | 0.9 | 12.3 | 15.7 | 0.3 | 1.3 | 0.0 |
| Financing Cash Flow | 13.4 | 5.4 | (24.1) | (2.9) | 48.0 | 436.1 | 41.9 | 10.2 | 7.0 | 0.0 |
| Cash Position | ||||||||||
| Net Change in Cash | (61.1) | (55.0) | (45.1) | 21.4 | (90.4) | 391.5 | 34.6 | 11.6 | 16.9 | (14.4) |
| Cash at Beginning | 293.9 | 348.9 | 394.0 | 372.6 | 463.0 | 71.5 | 36.8 | 25.2 | 8.3 | 16.7 |
| Cash at End | 232.8 | 293.9 | 348.9 | 394.0 | 372.6 | 463.0 | 71.5 | 36.8 | 25.2 | 2.3 |
| Free Cash Flow | (74.3) | (60.4) | (21) | 24.3 | (138.4) | (44.6) | (7.3) | (22.2) | (0.7) | (19.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 67.2 | 138.4 | 157.7 | 205.8 | 12.4 | 9.5 | 20.8 | 15.8 | 13.0 | 20.4 | 6.1 | 0 | 0 | 0 | 0 |
| Gross Profit | 64.2 | 138.4 | 157.7 | 205.8 | 12.4 | (46.4) | 20.8 | (1.2) | 12.6 | 20.1 | 6.1 | 0 | 0 | 0 | 0 |
| Operating Income | (75.0) | (95.7) | (78.2) | 12.2 | (202.9) | (71.5) | (25.5) | (21.8) | (10.5) | (25.2) | (19.7) | (33.1) | (10.3) | (1.5) | (3.9) |
| Net Income | (65.8) | (80.9) | (29.7) | 9.3 | (203.7) | (72.1) | (26.0) | (21.8) | (10.9) | (24.6) | (19.4) | (32.8) | (10.5) | (1.6) | (3.9) |
| EPS (Diluted) | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | -3.55 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 230.9 | 237.0 | 292.0 | 391.9 | 370.5 | 462.9 | 71.4 | 36.7 | 25.0 | 2.3 | |||||
| Total Assets | 271.1 | 344.1 | 429.4 | 450.4 | 392.8 | 476.5 | 82.1 | 44.2 | 52.0 | 51.6 | |||||
| Total Debt | 25.0 | 28.6 | 30.2 | 94.8 | 69.1 | 20.8 | 20.7 | 9.9 | 0 | 0.1 | |||||
| Stockholders' Equity | 214.0 | 241.0 | 278.5 | 270.3 | 228.2 | 396.6 | 25.8 | 13.6 | 33.8 | 47.2 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (74.3) | (59.7) | (18.1) | 32.0 | (135.0) | (42.9) | (6.4) | (20.8) | (0.5) | (19.2) | |||||
| Capital Expenditure | (0.2) | (0.6) | (2.9) | (7.7) | (3.4) | (1.7) | (0.8) | (1.5) | (0.3) | (0.1) | |||||
| Free Cash Flow | (74.3) | (60.4) | (21) | 24.3 | (138.4) | (44.6) | (7.3) | (22.2) | (0.7) | (19.3) | |||||